Andrew J. Perlman
CIK: 0001201617
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RCUS
Arcus Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
About PERLMAN ANDREW J
PERLMAN ANDREW J (SEC CIK 0001201617) files insider reports with the SEC as Director of Arcus Biosciences, Inc. (RCUS).
Signal8 holds 2 ownership filings by PERLMAN ANDREW J, all Form 4s, filed between Jun 12, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jun 10, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PERLMAN ANDREW J's filings is in HAYWARD, CA.
Recent filings by PERLMAN ANDREW J
Other insiders filing for Arcus Biosciences, Inc. (RCUS)
- Azoy Alexander, Chief Accounting Officer
- Jaen Juan C., President
- Lambert Nicole, Director
- Machado Patrick, Director
- KANEKO YASUNORI, Director
- Tang Carolyn C., General Counsel